Last 395.00 GBp
Change Today +3.30 / 0.84%
Volume 128.0K
UDG On Other Exchanges
As of 11:35 AM 01/28/15 All times are local (Market data is delayed by at least 15 minutes).

udg healthcare plc (UDG) Snapshot

396.00 GBp
Previous Close
391.70 GBp
Day High
396.00 GBp
Day Low
391.30 GBp
52 Week High
01/14/15 - 406.40 GBp
52 Week Low
10/13/14 - 315.20 GBp
Market Cap
Average Volume 10 Days
0.46 GBp
Shares Outstanding
0.11 GBp
Dividend Yield
Current Stock Chart for UDG HEALTHCARE PLC (UDG)

Related News

No related news articles were found.

udg healthcare plc (UDG) Related Businessweek News

No Related Businessweek News Found

udg healthcare plc (UDG) Details

UDG Healthcare plc, together with its subsidiaries, provides supply chain, packaging, medical, regulatory, and sales and marketing services to healthcare manufacturers and pharmacies operating in the Republic of Ireland, the United Kingdom, North America, and continental Europe. It operates through three segments: Supply Chain Services, Sharp Packaging Services, and Ashfield Commercial & Medical Services. The company offers integrated logistics and associated commercial services for pharmaceutical, biotech, and consumer companies in the areas of pharma wholesale, pre-wholesale comprising bulk distribution, and information services. It also provides clinical and commercial packaging, storage, logistics, and project management services to the pharmaceutical and biotech industries. In addition, the company offers outsourced services, including sales and marketing, healthcare communications, event management, medical affairs, and regulatory services to healthcare professionals and patients. Further, it provides healthcare communications and consultancy services; specialist healthcare and scientific public relations; clinical trials services; sales force effectiveness training services; and services in the travel health field, as well as distributes medical equipment and consumables, surgical products, laboratory equipment, and pharmaceutical products. The company was formerly known as United Drug plc and changed its name to UDG Healthcare plc in August 2013. UDG Healthcare plc was founded in 1948 and is based in Dublin, Ireland.

7,477 Employees
Last Reported Date: 12/18/14
Founded in 1948

udg healthcare plc (UDG) Top Compensated Officers

Chief Executive Officer, Executive Director a...
Total Annual Compensation: €978.0K
Chief Financial Officer and Executive Directo...
Total Annual Compensation: €666.0K
Chief Operating Officer and Executive Directo...
Total Annual Compensation: €629.0K
Managing Director of Ashfield Commercial & Me...
Total Annual Compensation: €595.0K
Compensation as of Fiscal Year 2014.

udg healthcare plc (UDG) Key Developments

UDG Healthcare plc Proposes Final dividend for the Year Ended September 30, 2014 Payable on February 23, 2015; Announces Board Changes; Announces Unaudited Consolidated Earnings Results for the Year Ended September 30, 2014; Provides Earnings Guidance for the year of 2015

The directors of UDG Healthcare plc are proposing a final dividend for the year ended September 30, 2014 of 7.43 cent per share, which represents a 7% increase on the 2013 final dividend of 6.95 cent per share. This gives a total dividend for the year of 10.12 cent per share, an increase of 6% on the total 2013 dividend. Subject to shareholder approval at the Company's 2015 Annual General Meeting, the proposed final dividend of 7.43 cent per share will be paid on 23 February 2015 to ordinary shareholders on the Company's register on 28 November 2014. The company also reported that Gary McGann and John Peter have announced their intention to retire from the board of UDG Healthcare, having served for ten years and nine years, respectively. Gary is stepping down from the board and as a member of the Risk, Acquisitions & Finance Committee with immediate effect. John will continue as a director, chairman of the remuneration committee and as a member of the audit committee, until the conclusion of the company's annual general meeting, to be held on February 3, 2015. In anticipation of John's retirement, Linda Wilding has been appointed to the remuneration committee and Gerard van Odijk has been appointed to the audit committee. Upon John's retirement, Linda Wilding will become the chairperson of the remuneration committee. The company also provided earnings guidance for the year of 2014. For the period, the Group expects to achieve operating profit growth in 2015 as the strong growth trend in Ashfield and Sharp, which will account for approximately 70% of the Group profits in 2015, more than offsets the anticipated decline in the Supply Chain Services division. The company remains very positive about the future growth prospects. The company also announced audited consolidated earnings results for the year ended September 30, 2014. For period, the company announced revenue of EUR 2,126,895,000 compared to EUR 2,033,024,000 for the same period a year ago. Operating profit was EUR 141,013,000 compared to EUR 47,701,000 for the same period a year ago. Profit before tax was EUR 125,023,000 compared to EUR 33,848,000 for the same period a year ago. Profit attributable to owners of the parent company was EUR 110,380,000 compared to EUR 27,548,000 for the same period a year ago. Earnings per share, diluted were 45.34 cents compared to 11.43 cents for the same period a year ago. On adjusted basis, the company reported the revenues of EUR 2,126.9 million, operating profit of EUR 102.6 million and profit after tax of EUR 70.0 million. Adjusted diluted earnings per share were 28.77 cents compared to 26.73 cents for the same period a year ago. Net cash inflow from operating activities was EUR 63,689,000 compared to EUR 77,542,000 for the same period a year ago. Purchase of property, plant and equipment was EUR 24,250,000 compared to EUR 39,272,000 for the same period a year ago. The Group invested EUR 38.1 million in capital expenditure during the year, mainly relating to the ERP system in the Republic of Ireland and increased automation in both Sharp and United Drug (ROI). Net debt as on September 30, 2014 was EUR 246.4 million against EUR 237.8 million as on September 30, 2013.

UDG Healthcare plc Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-20-2014 03:00 PM

UDG Healthcare plc Presents at Jefferies 2014 Global Healthcare Conference: London, Nov-20-2014 03:00 PM. Venue: The Waldorf Hilton, Aldwych, London, United Kingdom.

UDG Healthcare plc, 2014 Earnings Call, Nov 20, 2014

UDG Healthcare plc, 2014 Earnings Call, Nov 20, 2014


Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
UDG:LN 395.00 GBp +3.30

UDG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Cardinal Health Inc $86.02 USD +1.32
Celesio AG €26.50 EUR -0.237
CMIC Holdings Co Ltd ¥1,993 JPY -27.00
EPS Holdings Inc ¥1,468 JPY +28.00
View Industry Companies

Industry Analysis


Industry Average

Valuation UDG Industry Range
Price/Earnings 5.7x
Price/Sales 0.3x
Price/Book 1.2x
Price/Cash Flow 5.6x
TEV/Sales 0.0x

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact UDG HEALTHCARE PLC, please visit Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at